Free Trial

Genocea Biosciences (GNCA) Insider Trading & Ownership

Genocea Biosciences (NASDAQ:GNCA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.61%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
7
Amount Of
Insider Selling
(Last 3 Years)
$791,721.35
Get GNCA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Genocea Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GNCA Insider Buying and Selling by Quarter

Genocea Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/1/2022Jacquelyn L SumerInsiderSell2,500$0.06$150.00  
5/31/2022William D ClarkCEOSell117,244$0.06$7,034.64  
5/26/2022Diantha DuvallCFOSell24,407$0.08$1,952.56  
5/25/2022Ali BehbahaniDirectorSell4,445,093$0.08$355,607.44  
5/25/2022Jessica Baker FlechtnerInsiderSell16,525$0.09$1,487.25  
5/24/2022Paul Edward WalkerMajor ShareholderSell5,931,843$0.07$415,229.01  
4/4/2022Diantha DuvallCFOSell963$1.25$1,203.75  
4/4/2022Jessica Baker FlechtnerInsiderSell1,212$1.25$1,515.00  
4/4/2022William D ClarkCEOSell3,924$1.25$4,905.00  
3/16/2022Girish N AakaluInsiderSell2,397$1.10$2,636.70  
(Data available from 1/1/2013 forward)

GNCA Insider Trading Activity - Frequently Asked Questions

Who is on Genocea Biosciences's Insider Roster?

The list of insiders at Genocea Biosciences includes Ali Behbahani, Diantha Duvall, Girish N Aakalu, Jacquelyn L Sumer, Jessica Baker Flechtner, Paul Edward Walker, and William D Clark. Learn more on insiders at GNCA.

What percentage of Genocea Biosciences stock is owned by insiders?

1.61% of Genocea Biosciences stock is owned by insiders. Learn more on GNCA's insider holdings.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:GNCA) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners